China-focused PE firm Blue Ocean Capital has exited US-listed China Cord Blood Corporation (CCBC), by selling its beneficial interest in the blood bank operator to a fund sponsored by Chinese conglomerate Sanpower Group.
The GP committed $250 million in December 2015 in support of a privatization of CCBC launched by Hong Kong-listed Golden Meditech, which was at the time the company's largest shareholder. Blue Ocean subscribed...
Team turnover remains a key concern for LPs making commitments to Chinese private equity firms, but even the most stable of GPs must demonstrate an ability to evolve in response to a fast-changing environment, investors caution.
Redpoint China Ventures has closed its debut renminbi-denominated VC fund at RMB700 million ($110 million).
India’s National Investment & Infrastructure Fund has acquired a controlling stake in PE-backed logistics player Continental Warehousing Corporation (CWCNSL) in a joint deal with Dubai-based port operator DP World.
HarbourVest Partners has closed its latest fund-of-funds targeting European and Asian markets with $1.7 billion in commitments.